Mental Health in Autistic Adults: An RDoC Approach
成人自闭症患者的心理健康:RDoC 方法
基本信息
- 批准号:10523166
- 负责人:
- 金额:$ 51.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-06 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAdultAdverse eventAgeAgingAlgorithmsAnxietyAppointmentAttention deficit hyperactivity disorderBiological MarkersBrainClinicalClinical DataCollaborationsCommunicationCommunitiesConsentCrisis InterventionDataDiagnosisDiagnosticDifferential DiagnosisDimensionsDocumentationElectronic MailEnrollmentEnsureEthnic OriginFeeling suicidalFemaleFundingFunding MechanismsGoalsGrantHealth PersonnelIndividualIntellectual functioning disabilityLeadMachine LearningMeasuresMental DepressionMental HealthMethodsMonitorNewsletterParticipantPersonality DisordersPersonsPhenotypeProbabilityProceduresProcessProductivityProtocols documentationPsychiatric DiagnosisRaceRecording of previous eventsRecruitment ActivityRegistriesReportingResearchResearch Domain CriteriaResearch PersonnelResearch Project GrantsResourcesRiskRuralSafetyScheduleServicesStructureSuicideSymptomsSystemTimeTrainingUlysses ContractsUncertaintyUnited States National Institutes of HealthUpdateVisitadult with autism spectrum disorderage relatedautism spectrum disorderautisticbasecognitive testingcohortdiagnostic screeningethnic identityexperiencehuman old age (65+)inclusion criteriaindexinginnovationmarginalized populationmeetingsnovelparticipant retentionphenotypic dataprogramsracial identityrecruitresponsesatisfactionservice interventionsexsuccesssuicidal behaviorsuicidal risktheoriestool
项目摘要
Clinical Core Abstract
The purpose of the Clinical Core is 1): To manage recruitment activities and consent and enroll a Pittsburgh
ACE Cohort for participation in the three Projects. We will prioritize increased participation by individuals
traditionally minoritized in ASD research (e.g., race/ethnicity, LGBTQIA+, females, and diagnosis of ASD in
adulthood); 2): Administer, score, and enter data for ASD diagnostic assessments and administer all RFA-
required and center-wide phenotypic measures; 3) Apply a novel posterior probability of diagnosis (PPOD)
index to estimate the presence of psychiatric diagnoses and ASD; 4) Establish age-related variables for use
across Projects, including a biomarker of brain age and documentation of age of ASD diagnosis; 5) Manage
scheduling of participants for all Projects. 6) Support retention of participants and monitor progress through
Projects; 7) Monitor risks related to suicidality and other adverse events, and 8) To collaborate with other
Cores and Projects. The Core will enroll 200 autistic and 100 non-autistic 18- to 65-year-old adults (>50 in
each group with a recent history of suicidal ideation or behaviors [SI/SB], defined as active SI/SB within the
past four months). We anticipate needing to consent and assess approximately 100 additional individuals to
account for those who do not meet inclusion criteria. Those meeting study inclusion criteria will be invited to
participate in all three Projects. Our team has consistently met recruitment goals for numerous NIH-funded
studies of autistic adults, we have active partnerships with several registries for autistic and non-autistic adults,
and we will collaborate with the Dissemination and Partnership Core to enhance our inclusion of autistic adults
from groups that have been marginalized. The Clinical Core organizes the extensive recruitment effort to
assure the Projects meet their targeted enrollments and complete their proposed studies, while assuring all the
data mandated by the ACE funding mechanism is collected. The centralization of these services in a Core
combines the recruitment resources that would otherwise be distributed across Projects, thereby reducing the
redundancy and inefficiency that would occur if each Project had to perform these efforts individually.
Research-reliable Clinical Core staff will conduct ASD diagnostic and cognitive assessments using the tools
outlined in the RFA; this also creates an efficient process and supports the collaboration of investigators new to
autism in this ACE center. Finally, Clinical Core staff are highly experienced in the assessment of SI/SB and
psychiatric diagnoses and will monitor for suicide-related risks.
临床核心摘要
临床核心的目的是1):管理招聘活动并同意并注册匹兹堡
ACE队列参加这三个项目。我们将优先考虑个人的参与
传统上在ASD研究(例如种族/种族,LGBTQIA+,女性和ASD诊断ASD中的ASD少数
成年); 2):管理,评分和输入ASD诊断评估的数据,并管理所有RFA-
必需和中央范围的表型措施; 3)应用新颖的后验诊断概率(PPOD)
估计精神诊断和ASD的存在的索引; 4)建立与年龄相关的变量供使用
在整个项目中,包括脑年龄的生物标志物以及ASD诊断年龄的记录; 5)管理
为所有项目的参与者安排。 6)支持保留参与者并通过
项目; 7)监控与自杀性和其他不良事件有关的风险,以及8)与其他合作
核心和项目。核心将注册200名自闭症和100个非自动主义18至65岁的成年人(> 50英寸
每个具有自杀意念或行为[Si/SB]的近期历史的组,定义为活性SI/SB
过去四个月)。我们预计需要同意并评估大约100个个人
说明那些不符合纳入标准的人。那些会议研究的纳入标准将被邀请
参加所有三个项目。我们的团队一直为众多NIH资助而实现招聘目标
研究自闭症成年人,我们与几个自闭症和非自闭症成年人的注册表建立了积极的伙伴关系,
我们将与传播和伙伴关系核心合作,以增强我们的自闭症成年人的包含
来自被边缘化的群体。临床核心组织了广泛的招聘工作
确保项目符合其目标入学率并完成拟议的研究,同时确保所有
收集了由ACE融资机制规定的数据。这些服务的集中化核心
结合招募资源,否则将在项目中分发,从而减少
如果每个项目都必须单独执行这些努力,将会发生冗余和效率低下。
可靠的可靠临床核心人员将使用工具进行ASD诊断和认知评估
在RFA中概述;这也创造了一个有效的过程,并支持新手的调查人员合作
在这个王牌中心的自闭症。最后,临床核心人员在评估SI/SB和
精神科诊断,将监测与自杀有关的风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BENJAMIN L HANDEN其他文献
BENJAMIN L HANDEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BENJAMIN L HANDEN', 18)}}的其他基金
Mental Health in Autistic Adults: An RDoC Approach
成人自闭症患者的心理健康:RDoC 方法
- 批准号:
10698092 - 财政年份:2022
- 资助金额:
$ 51.02万 - 项目类别:
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)
阿尔茨海默病生物标志物联盟 - 唐氏综合症 (ABC-DS)
- 批准号:
10530789 - 财政年份:2020
- 资助金额:
$ 51.02万 - 项目类别:
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)
阿尔茨海默病生物标志物联盟 - 唐氏综合症 (ABC-DS)
- 批准号:
10454470 - 财政年份:2020
- 资助金额:
$ 51.02万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children
用于儿童抗病毒治疗的剂量灵活组合 3D 打印输送系统
- 批准号:
10682185 - 财政年份:2023
- 资助金额:
$ 51.02万 - 项目类别:
Transovarial transmission of yersinia pestis in fleas
跳蚤中鼠疫耶尔森氏菌的跨卵巢传播
- 批准号:
10727534 - 财政年份:2023
- 资助金额:
$ 51.02万 - 项目类别:
Ultra-long-acting Biodegradable and Tunable Polymeric Solid Implant for HIV Treatment Maintenance
用于维持艾滋病毒治疗的超长效可生物降解和可调聚合物固体植入物
- 批准号:
10759149 - 财政年份:2023
- 资助金额:
$ 51.02万 - 项目类别:
Improving Cardiorespiratory Fitness and Cardiometabolic Health among Children with Physical Disabilities through Movement-to-Music Telehealth with Arm-based Sprint-Intensity Interval Training
通过运动音乐远程医疗和基于手臂的冲刺强度间歇训练,改善身体残疾儿童的心肺健康和心脏代谢健康
- 批准号:
10645848 - 财政年份:2023
- 资助金额:
$ 51.02万 - 项目类别:
Targeting Senescence to Improve Frailty in Older Cancer Survivors
瞄准衰老以改善老年癌症幸存者的虚弱状况
- 批准号:
10866293 - 财政年份:2023
- 资助金额:
$ 51.02万 - 项目类别: